Development and validation of a stability-indicating HPLC method for the determination of buclizine hydrochloride in tablets and oral suspension and its application to dissolution studies
AUTOR(ES)
Kuminek, Gislaine, Stulzer, Hellen K., Tagliari, Monika P., Oliveira, Paulo R., Bernardi, Larissa S., Rauber, Gabriela, Cardoso, Simone G.
FONTE
Química Nova
DATA DE PUBLICAÇÃO
2012
RESUMO
A method using liquid chromatography has been developed and validated for determination of buclizine in pharmaceutical formulations and in release studies. Isocratic chromatography was performed on a C18 column with methanol:water (80:20 v/v, pH 2.6) as mobile phase, at a flow rate of 1.0 mL/min, and UV detection at 230 nm. The method was linear, accurate, precise, sensible and robust. The dissolution test was optimized and validated in terms of dissolution medium, apparatus agitation and rotation speed. The presented analytical and dissolution procedures can be conveniently adopted in the quality and stability control of buclizine in tablets and oral suspension.
Documentos Relacionados
- Stability-indicating RP-HPLC method for determination of beclomethasone dipropionate in nanocapsule suspensions
- Stability-indicating RP-HPLC method for simultaneous determination of gatifloxacin and flurbiprofen in binary combination
- Development and validation of a stability indicating HPLC method to determine diltiazem hydrochloride in tablets and compounded capsules
- Development and validation of a stability-indicating UPLC method for rosuvastatin and its related impurities in pharmaceutical dosage forms
- Development and Validation of a Stability-Indicating Method for Perillyl Alcohol Incorporated in Poly(lactide-co-glycolide) Nanoparticles and Stress Degradation Studies